Researchers Question PET/CT Follow-Up Rule

A recently published study in the Journal of Nuclear Medicine, found that a fourth and subsequent follow-up FDG PET/CT studies do in fact add value to clinical assessment and treatment planning strategy to lung cancer patients with advanced disease.

"We need to see whether that treatment needs to be altered to the advantage of the patient," says Ella Kazerooni, M.D., M.S., division director of cardiothoracic radiology at the University of Michigan. "Setting a limit on the number of PET/CTs the treating physicians can order is unfair to patients in this era of personalized medicine", she says.